Manufacturing

Vaccine research
#Biologics #Chiesi #Manufacturing #Monoclonal antibodies

Chiesi opens €400m Biotech Center of Excellence in Italy

Chiesi Group has launched its Biotech Center of Excellence, dedicated to developing and producing monoclonal antibodies, enzymes, and other proteins, in Parma, Italy. From the production of drug substances from mammalian cells to their transformation into drug products and final packaging, the company says that everything will be done in… Read More

#Business & Investment #News

Antibodies
#Antibody discovery workflow #Biosafety testing #Infographic #Manufacturing #Monoclonal antibodies

Infographic: Discover how to optimise mAb manufacturing

A new Infographic is now available to download from Thermo Fisher Scientific, entitled ‘Optimize Your mAb Manufacturing with Proven Analytical Strategies‘. Key takeaways: Boost Workflow Efficiency: Discover how end-to-end testing can enhance the efficiency of your monoclonal antibody production process. Ensure Compliance: Learn about the importance of accurate and… Read More

#News

#Antibody discovery workflow #Biosafety testing #Manufacturing #Monoclonal antibodies

Optimize Your mAb Manufacturing with Proven Analytical Strategies

Key takeaways: Boost Workflow Efficiency: Discover how end-to-end testing can enhance the efficiency of your monoclonal antibody production process. Ensure Compliance: Learn about the importance of accurate and precise testing at various production stages to meet or exceed regulatory guidelines. Guarantee Quality: Understand how proper testing ensures product safety, quality, and potency throughout… Read More

#Intelligence #Resources

CAR-T therapy
#CAR-T #Caring Cross #Cell and gene therapy #Collaboration #GermFree #Manufacturing

Collaboration plans to democratise cell and gene therapies

Modular cleanroom company GermFree and non-profit Caring Cross have announced a new partnership, hoping to make cellular gene therapies more available to patients. The companies plan to create a decentralised, point-of-care manufacturing model that combines GermFree’s mobile cleanroom units with Caring Cross’s manufacturing technologies and pipeline… Read More

#News

Cell therapy platform
#Cell and gene therapy #Drug discovery #GMP #Infographic #Manufacturing

Infographic: Overcome your cell and gene therapy (GMP) challenges

A new infographic is now available to download for free from Thermo Fisher Scientific. Download this interactive infographic to: Discover ways to navigate your contamination, compliance, reproducibility, monitoring and scalability challenges Identify which critical factors and equipment you should consider to help succeed in a GMP environment… Read More

#News

#Cell and gene therapy #Cell therapy #Collaboration #Manufacturing #Partnership

Partnership to speed up cell therapy delivery

Autolomous and BioCentriq have collaborated to digitise and accelerate process development and manufacturing activities for cell therapy. Autolomous’ software platform is designed to materially affect the cell and gene therapy sector. BioCentriq will leverage the autoloMATE platform to streamline its process development operations and enhance client experience. This partnership aims… Read More

#Business & Investment #News

View from the International Space Station
#Antibodies #BioOrbit #Manufacturing #Start-ups #Therapeutic Antibodies

Why Carol Vorderman’s daughter is taking antibodies into space

A UK-based start-up is developing technology to build a pharmaceuticals factory in space that will make antibody treatments more accessible and easier to administer. BioOrbit is aiming to build the first pharmaceuticals factory in microgravity and are currently developing a platform for large-scale crystallisation of protein… Read More

#Editor's Choice #News #Start-up Zone

Miami skyline
#Advanced Therapies #Cell and gene therapy #Drug development #Manufacturing #Viral vectors

What challenges does the advanced therapies sector face? 

Over the three days of Advanced Therapies Week (ATW) 2024 in Miami, Florida, US, 16-19 January 2024, DDW’s Megan Thomas heard from attendees about the obstacles the sector needs to overcome to succeed.   Viral vector manufacturing   At the Advanced Therapies Awards ceremony, Dr Luigi Naldini, Director of the San Raffaele… Read More

#Exclusive Content #Opinion #Regulatory

#BioIVT #Cell and gene therapy #Cell therapy #GMP #Manufacturing #Regulatory #Webinar

Webinar: Avoid unnecessary delays getting cell therapies to market

Both GTPs and GMPs must be followed to get cell-based advanced therapies or tissue-based therapy products to market. Learn about important considerations when sourcing Leukocytes/Cellular starting materials and related ancillary products that must be factored into your programme to efficiently move through the clinical pipeline and successfully receive regulatory approval. Read More

#News

Cell and gene therapy
#CDMO #Cell and gene therapy #eBook #Gene therapy #Manufacturing

eBook: Analytical methods for viral vector development in gene therapy

The eleventh eBook of the Hamilton series ‘Analytical Methods for Viral Vector Development and Manufacturing in Gene Therapy’ is now available. Download the eBook to learn about: Gene therapy: history, viral vectors and the role of CDMOs Automation of analytical assays during viral vector development and manufacturing… Read More

#News

#CDMO #Cell and gene therapy #Gene therapy #Manufacturing

Analytical methods for viral vector development and manufacturing in gene therapy

In the eleventh eBook of the Hamilton series ‘Analytical Methods for Viral Vector Development and Manufacturing in Gene Therapy’, we learn about: Gene therapy: history, viral vectors and the role of CDMOs Automation of analytical assays during viral vector development and manufacturing The solutions that Hamilton offers to customers working… Read More

#Resources

Vaccine production
#Collaboration #Immunology / Virology & Vaccines #Lifera #Manufacturing #Sanofi #Saudi Arabia

Partners agree to boost vaccine accessibility in Saudi Arabia

Saudi Arabian company Lifera is partnering with Sanofi and Arabio to strengthen local manufacturing of vaccines in Saudi Arabia. Under the terms of the Memorandum of Understanding (MOU), Lifera, Sanofi and Arabio will explore opportunities for collaboration to help advance Saudi Arabia’s vaccines localisation strategy through… Read More

#News

#AI / data analytics / healthtech / informatics #Data management #Drug discovery #Life sciences #Manufacturing #PCR

The latest drug discovery product launches

Find out what’s new in the world of tools and services for the drug discovery industry with our update below.  CFX Opus Deepwell Dx Real-Time PCR System – Bio-Rad Laboratories  Bio-Rad Laboratories has launched the CFX Opus Deepwell Dx Real-Time PCR System, which offers accurate and precise quantification… Read More

#Editor's Choice #News

GenScript facility
#Biomanufacturing #Cell and gene therapy #Expansion #GenScript #Manufacturing

GenScript expands capacity for cell and gene therapy programmes

GenScript USA has expanded its global current Good Manufacturing Practices (cGMP) single-guide RNA (sgRNA) manufacturing capabilities to meet the growing demand for cell and gene therapies.  The 400,000 square-foot cGMP facility enables gene and cell therapy R&D programmes to advance IND filings and clinical trials. The company’s… Read More

#News

Cell culture media
#Biologics #Bioproduction #Cell and gene therapy #Cell therapy #Life sciences #Manufacturing

Fujifilm expands cell culture media manufacturing

Fujifilm Corporation has announced a $188 million investment to establish a cell culture media manufacturing facility in Research Triangle Park (RTP), North Carolina, USA.  The new site will be operated by Fujifilm Irvine Scientific, a manufacturer of cell culture solutions for life science research, bioproduction, cell therapy… Read More

#News

Builders checking plans
#Biologics / Biotechnology #Biotech hubs #Cell and gene therapy #Drug discovery #Expansion #Investment #Laboratory #Manufacturing

Space to innovate: where are biotech’s top expansions?

Expansions to laboratory space throughout the drug discovery industry can only be a good thing – new centres of innovation will bring more space to grow, more advanced technologies, improved sustainability and new employment opportunities.  While there have been a significant number of new facilities built in the US,… Read More

#Editor's Choice #News